Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
M.D. Anderson Cancer Center
Endeavor Biomedicines, Inc.
Universidad Nacional Autonoma de Mexico
Pfizer
Yale University
Vanderbilt-Ingram Cancer Center